Bindal Shivani, El Ahmadieh Tarek Y, Plitt Aaron, Aoun Salah G, Neeley Om James, El Tecle Najib E, Barnett Samuel, Gluf Wayne
Department of Neurological Surgery, The University of Texas Southwestern, Dallas, TX, United States.
Department of Neurological Surgery, The University of Texas Southwestern, Dallas, TX, United States.
J Clin Neurosci. 2019 Apr;62:162-173. doi: 10.1016/j.jocn.2018.11.037. Epub 2018 Nov 22.
Schwannomas of the hypoglossal nerve are rare and account for a very small percentage of non-vestibular schwannomas.
In this systematic review of the literature, we examined the epidemiology, symptomatology, management, and outcomes of patients with hypoglossal schwannomas.
The electronic database Pubmed was searched for all reports of hypoglossal schwannomas with descriptions of symptoms, management, and outcome characteristics. Data was extracted from each study and compiled in a spreadsheet. Continuous variables were reported as means and medians. Categorical variables were reported as proportions. Additional analysis was not done due to inconsistent reporting of outcomes and small sample sizes.
A total of 59 studies (94 total individual cases) were included. 64% of patients were female with mean age of 44.6 years. The majority were intracranial/extracranial (50%). The most common symptoms were tongue deviation or speech disturbance (38%) and headaches (33%). Hypoglossal nerve dysfunction was present in 80% of patients. Surgical excision was performed in 93%, with a 15% complication rate. Evidence of residual mass after surgery was noted in 29%. Permanent hypoglossal nerve deficits occurred in 67%. Recurrence of tumor burden was reported in 6 studies, with median time to recurrence of 16.5 months.
Current evidence suggests overall favorable outcomes with surgical resection of hypoglossal schwannomas, with a large percentage of patients experiencing mild and usually well-tolerated neurologic deficit. Limitations of this study include the use of retrospective data taken from case reports/series with highly selected patients, selective reporting, and absence of control groups.
舌下神经鞘瘤罕见,在非前庭神经鞘瘤中占比极小。
在本系统文献综述中,我们研究了舌下神经鞘瘤患者的流行病学、症状学、治疗及预后情况。
在电子数据库PubMed中检索所有关于舌下神经鞘瘤的报告,这些报告需描述症状、治疗及预后特征。从每项研究中提取数据并整理到电子表格中。连续变量以均值和中位数形式报告。分类变量以比例形式报告。由于结果报告不一致及样本量小,未进行进一步分析。
共纳入59项研究(94例个体病例)。64%的患者为女性,平均年龄44.6岁。大多数为颅内/颅外病变(50%)。最常见的症状是舌偏斜或言语障碍(38%)和头痛(33%)。80%的患者存在舌下神经功能障碍。93%的患者接受了手术切除,并发症发生率为15%。29%的患者术后有残留肿块迹象。永久性舌下神经缺损发生率为67%。6项研究报告了肿瘤负荷复发情况,复发的中位时间为16.5个月。
目前的证据表明,手术切除舌下神经鞘瘤总体预后良好,大部分患者出现轻度且通常耐受性良好的神经功能缺损。本研究的局限性包括使用来自病例报告/系列的回顾性数据,患者选择高度偏倚、选择性报告以及缺乏对照组。